About GuideTX
GuideTX is a company based in Tucker (United States) founded in 2019 by James Dahlman was acquired by Beam Therapeutics in February 2021.. GuideTX has raised $19.86 million across 4 funding rounds from investors including Beam Therapeutics, GreatPoint Ventures and Biomatics Capital. GuideTX operates in a competitive market with competitors including Candel Therapeutics, StrideBio, Genedit, Phase Genomics and Genenta Science, among others.
- Headquarter Tucker, United States
- Founders James Dahlman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.86 M (USD)
in 4 rounds
-
Latest Funding Round
$5.86 M (USD), Series A
Aug 11, 2020
-
Investors
Beam Therapeutics
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Beam Therapeutics
(Feb 23, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of GuideTX
GuideTX has successfully raised a total of $19.86M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $5.86 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $5.9M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Series A - GuideTX | Valuation |
investors |
|
| Jan, 2020 | Amount | Series A - GuideTX | Valuation |
investors |
|
| Apr, 2019 | Amount | Series A - GuideTX | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GuideTX
GuideTX has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Beam Therapeutics, GreatPoint Ventures and Biomatics Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on early-stage big data, health tech, AI, food tech, and multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage tech and life sciences focused VC firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
Developer of gene therapy using CRISPR base editing to treat diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GuideTX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GuideTX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Guidetx Comparisons
Competitors of GuideTX
GuideTX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Candel Therapeutics, StrideBio, Genedit, Phase Genomics and Genenta Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Viral immunotherapies are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
AAV-based gene therapies for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| domain | founded_year | HQ Location |
Lentivirus-based gene and cell therapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GuideTX
When was GuideTX founded?
GuideTX was founded in 2019.
Where is GuideTX located?
GuideTX is headquartered in Tucker, United States. It is registered at Tucker, Georgia, United States.
Is GuideTX a funded company?
GuideTX is a funded company, having raised a total of $19.86M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Mar 01, 2019.
What does GuideTX do?
Founded in 2019 and based in Tucker, United States, GuideTx operates in the biotechnology sector focused on nucleic acid therapeutics. Delivery systems for DNA and RNA are developed to treat diseases at the genetic level. A flagship lipid nanoparticle is offered for RNA transport to hepatocytes, with FDA approval achieved. A proprietary screening platform is utilized to create nanoparticles for functional delivery into cytoplasm or nucleus.
Who are the top competitors of GuideTX?
GuideTX's top competitors include Phase Genomics, Genenta Science and Genedit.
Who are GuideTX's investors?
GuideTX has 3 investors. Key investors include Beam Therapeutics, GreatPoint Ventures, and Biomatics Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.